These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 30245173)

  • 1. Skin nerve α-synuclein deposits in a parkinsonian patient with heterozygous parkin mutation.
    Fadda L; Lombardi R; Soliveri P; Lauria G; Giovanni Defazio ; Tagliavini F
    Parkinsonism Relat Disord; 2019 Mar; 60():182-183. PubMed ID: 30245173
    [No Abstract]   [Full Text] [Related]  

  • 2. Skin nerve α-synuclein deposits: a biomarker for idiopathic Parkinson disease.
    Donadio V; Incensi A; Leta V; Giannoccaro MP; Scaglione C; Martinelli P; Capellari S; Avoni P; Baruzzi A; Liguori R
    Neurology; 2014 Apr; 82(15):1362-9. PubMed ID: 24634456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skin nerve α-synuclein deposits: a biomarker for idiopathic Parkinson disease.
    Sharma SK
    Neurology; 2014 Oct; 83(17):1582. PubMed ID: 25332447
    [No Abstract]   [Full Text] [Related]  

  • 4. Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease.
    Shimura H; Schlossmacher MG; Hattori N; Frosch MP; Trockenbacher A; Schneider R; Mizuno Y; Kosik KS; Selkoe DJ
    Science; 2001 Jul; 293(5528):263-9. PubMed ID: 11431533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parkin and alpha-synuclein: opponent actions in the pathogenesis of Parkinson's disease.
    Baptista MJ; Cookson MR; Miller DW
    Neuroscientist; 2004 Feb; 10(1):63-72. PubMed ID: 14987449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interplay between parkin and alpha-synuclein; possible implications for the pathogenesis of Parkinson's disease.
    Jęśko H; Lenkiewicz AM; Wilkaniec A; Adamczyk A
    Acta Neurobiol Exp (Wars); 2019; 79(3):276-289. PubMed ID: 31587020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skin nerve misfolded α-synuclein in pure autonomic failure and Parkinson disease.
    Donadio V; Incensi A; Piccinini C; Cortelli P; Giannoccaro MP; Baruzzi A; Liguori R
    Ann Neurol; 2016 Feb; 79(2):306-16. PubMed ID: 26606657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skin Nerve Phosphorylated α-Synuclein Deposits in Parkinson Disease With Orthostatic Hypotension.
    Donadio V; Incensi A; Del Sorbo F; Rizzo G; Infante R; Scaglione C; Modugno N; Fileccia E; Elia AE; Cencini F; Liguori R
    J Neuropathol Exp Neurol; 2018 Oct; 77(10):942-949. PubMed ID: 30137426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenetic mechanisms of parkin in Parkinson's disease.
    Hattori N; Mizuno Y
    Lancet; 2004 Aug 21-27; 364(9435):722-4. PubMed ID: 15325839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of parkin in Parkinson's disease].
    Miklya I; Göltl P; Hafenscher F; Pencz N
    Neuropsychopharmacol Hung; 2014 Jun; 16(2):67-76. PubMed ID: 24978049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The regulatory role of α-synuclein and parkin in neuronal cell apoptosis; possible implications for the pathogenesis of Parkinson's disease.
    Yasuda T; Mochizuki H
    Apoptosis; 2010 Nov; 15(11):1312-21. PubMed ID: 20221696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Author response.
    Donadio V
    Neurology; 2014 Oct; 83(17):1582. PubMed ID: 25513640
    [No Abstract]   [Full Text] [Related]  

  • 13. Phosphorylated α-synuclein in skin nerve fibres differentiates Parkinson's disease from multiple system atrophy.
    Zange L; Noack C; Hahn K; Stenzel W; Lipp A
    Brain; 2015 Aug; 138(Pt 8):2310-21. PubMed ID: 26017579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lewy body Parkinson's disease in a large pedigree with 77 Parkin mutation carriers.
    Pramstaller PP; Schlossmacher MG; Jacques TS; Scaravilli F; Eskelson C; Pepivani I; Hedrich K; Adel S; Gonzales-McNeal M; Hilker R; Kramer PL; Klein C
    Ann Neurol; 2005 Sep; 58(3):411-22. PubMed ID: 16130111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inclusion body formation and neurodegeneration are parkin independent in a mouse model of alpha-synucleinopathy.
    von Coelln R; Thomas B; Andrabi SA; Lim KL; Savitt JM; Saffary R; Stirling W; Bruno K; Hess EJ; Lee MK; Dawson VL; Dawson TM
    J Neurosci; 2006 Apr; 26(14):3685-96. PubMed ID: 16597723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ubiquitin and Parkinson's disease through the looking glass of genetics.
    Walden H; Muqit MM
    Biochem J; 2017 Apr; 474(9):1439-1451. PubMed ID: 28408429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of parkin promotes lipid rafts-dependent endocytosis through accumulating caveolin-1: implications for Parkinson's disease.
    Cha SH; Choi YR; Heo CH; Kang SJ; Joe EH; Jou I; Kim HM; Park SM
    Mol Neurodegener; 2015 Dec; 10():63. PubMed ID: 26627850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small fiber neuropathy and phosphorylated alpha-synuclein in the skin of E46K-SNCA mutation carriers.
    Carmona-Abellan M; Gabilondo I; Murueta-Goyena A; Khurana V; Tijero B; Luquin MR; Acera M; Del Pino R; Gardeazabal J; Martínez-Valbuena I; Sanchez-Pernaute R; Gómez-Esteban JC
    Parkinsonism Relat Disord; 2019 Aug; 65():139-145. PubMed ID: 31178336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Parkin, alpha-synuclein and other molecular aspects of Parkinson's disease].
    Corti O; Brice A
    J Soc Biol; 2002; 196(1):95-10. PubMed ID: 12134640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. alpha-Synuclein and parkin: coming together of pieces in puzzle of Parkinson's disease.
    Burke RE
    Lancet; 2001 Nov; 358(9293):1567-8. PubMed ID: 11716878
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.